Gregory J. Nadolski, M.D.
Associate Professor of Radiology at the Hospital of the University of Pennsylvania
Co-Director, Penn Image Guided Interventions (PIGI) Laboratory
Active Radiologist, Penn Presbyterian Medical Center
Active Radiologist, Pennsylvania Hospital
Attending Radiologist, Hospital of the University of Pennsylvania
Director Research Oversight (Interventional Radiology), University of Pennsylvania
Chair IR/DR Residency Selection Committee, University of Pennsylvania
Department: Radiology
Contact information
Hospital of the University of Pennsylvania
Department of Radiology
1 Silverstein
3400 Spruce Street
Philadelphia, PA 19104
Department of Radiology
1 Silverstein
3400 Spruce Street
Philadelphia, PA 19104
Office: 215.662.7892
Fax: 215.615.3545
Fax: 215.615.3545
Education:
B.S. (Biochemistry)
University of Wisconsin, Madison, WI , 2001.
M.D. (Medicine)
Indiana University School of Medicine, Indianapolis, IN , 2007.
MS (Translational Research)
University of Pennsylvania, Philadelphia, PA, 2017.
Permanent linkB.S. (Biochemistry)
University of Wisconsin, Madison, WI , 2001.
M.D. (Medicine)
Indiana University School of Medicine, Indianapolis, IN , 2007.
MS (Translational Research)
University of Pennsylvania, Philadelphia, PA, 2017.
Description of Clinical Expertise
My research and clinical interests include multimodality therapies for the treatment of hepatocellular carcinoma and liver dominant metastatic cancer.I have initiated or participated in multiple clinical trials at the Hospital of the University of Pennsylvania for treating hepatocellular carcinoma and metastatic cancers to the liver. Several of these trials are multi-modality treatments in collaboration with other medical subspecialties.
My other area of clinical and research interest is lymphatic injury, dysfunction, and malformations. Clinically, I perform thoracic duct embolization to treat chylothorax. I participate in research investigating novel lymphatic interventions to treat chylothorax, chylous ascites, refractory ascites and protein losing enteropathy.
Description of Research Expertise
My clinical and research expertise center on lymphatic interventions and multimodality cancer therapies to treat primary and secondary liver tumors. I also conduct research on diseases of the liver such as treatment of portal hypertension and ascites.Selected Publications
Roberson JL, Gasior JA, Ginzberg SP, Bakillah E, Passman J, Shreve L, Sharoky CE, Nadolski G, Courtright KR, Kaufman EJ: The Impact of Palliative Decompressive Gastrostomy Tube Placement on Patients and Their Caregivers: A Mixed Methods Analysis. Annals of Surgical Oncology 31(10): 6931-6938, Oct 2024.Agrawal A, Chaddha U, Shojaee S, Nadolski G, Liberman M, Lee YCG, Rahman N, Reisenauer JS, Ferguson MK, DeCamp MM, Gillaspie EA, Bedawi EO, Currie B, Feller-Kopman DJ, Desai A, Yasufuku K, Bishay V, Gesthalter Y, Grosu H, Chick JFB, Lentz R, Kolli KP, Kaufman A, Mehta RM, Desai K, Davis H, Ghori UK, Maldonado F.: Multidisciplinary Management of Adult Patients with Chylothorax: A Consensus Statement. European Respiratory Journal September 2024 Notes: epub ahead of print.
Habibollahi P, Gurevich A, Hui JZ, Weinfurtner K, McClung G, Adler J, Soulen MC, Kaplan DE, Nadolski GJ, Hunt SJ, Tsourkas A, Gade TP.: Integrated imaging probe and bispecific antibody development enables in vivo targeting of glypican-3-expressing hepatocellular carcinoma. Molecular Cancer Therapeutics September 2024 Notes: epub ahead of print.
Matsumoto MM, Schisterman EF, Soulen MC, Reddy S, Sheng M, Khaddash T, Damjanov N, Furth EE, Hunt SJ, Nadolski GJ, Kaplan DE, Gade TPF: Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma: The Phase I-II qTACE Trial. JVIR August 2024 Notes: ahead of print.
Leon S, Rouhi AD, Roberson JL, Shreve LA, Nadolski GJ, Williams NN, Dumon KR.: Safety of elective enteral access in elderly patients: a comparative analysis of perioperative risk. Journal of Gastrointestinal Surgery June 2024 Notes: ahead of print.
X. Li,C. O'Leary,A. Gurevich,G. Nadolski,M. Asher,M. Itkin: Diagnosis and Lymphatic Embolization in Managing Plastic Bronchitis: Risk Factors, Outcomes, and Long-Term Follow-up. JVIR 35(3): S9, March 2024.
T. Truong,S. Hunt,T. Gade,J. Mondschein,M. Soulen,G. Nadolski: Treatment of Hepatic Post-Microwave Ablation Recurrence: Is Repeat Ablation the Best Option? JVIR 34(3): S159-160, March 2024.
M. Hung1 ∙ A. Jairam2 ∙ M. Carr2 ∙ Z. Berman3 ∙ M. Taddonio2 ∙ J. Minocha4 ∙ H. Aryafar5 ∙ J. Mondschein6 ∙ M. Soulen6 ∙ G. Nadolski6 ∙ J. Redmond: Transjugular Intrahepatic Portosystemic Shunt Creation Using Intravascular Ultrasound versus Fluoroscopic Guidance: A Dual-Institution Retrospective Comparative Study. JVIR 34(3): S123, March 2024.
A. Gurevich,M. Asher,G. Nadolski,D. Rabinowitz,M. Itkin: Refractory Lymphatic Ascites After Liver Transplantation: Identification of the Underlying Mechanism of Ascites Permits Successful Percutaneous Treatment. JVIR 34(3): S109-110, March 2024.
Gregory Nadolski and Maxim Itkin: Lymphatic Interventions. IR Playbook: A Comprehensive Introduction to Interventional Radiology. Nicole A. Keefe, Ziv J.J Haskal, Auh Whan Park, John F. Angle (eds.). 2: 325-332, 2024.